rs16958350
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_052867.4(NALCN):c.2637-10T>G variant causes a intron change. The variant allele was found at a frequency of 0.025 in 1,613,486 control chromosomes in the GnomAD database, including 680 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 73 hom., cov: 33)
Exomes 𝑓: 0.025 ( 607 hom. )
Consequence
NALCN
NM_052867.4 intron
NM_052867.4 intron
Scores
2
Splicing: ADA: 0.8343
2
Clinical Significance
Conservation
PhyloP100: 4.23
Publications
4 publications found
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
- congenital contractures of the limbs and face, hypotonia, and developmental delayInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- hypotonia, infantile, with psychomotor retardation and characteristic facies 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- digitotalar dysmorphismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Freeman-Sheldon syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Sheldon-hall syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypotonia, infantile, with psychomotor retardation and characteristic faciesInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- temporal lobe epilepsyInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 13-101104660-A-C is Benign according to our data. Variant chr13-101104660-A-C is described in ClinVar as Benign. ClinVar VariationId is 262258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0634 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NALCN | NM_052867.4 | c.2637-10T>G | intron_variant | Intron 23 of 43 | ENST00000251127.11 | NP_443099.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NALCN | ENST00000251127.11 | c.2637-10T>G | intron_variant | Intron 23 of 43 | 1 | NM_052867.4 | ENSP00000251127.6 |
Frequencies
GnomAD3 genomes AF: 0.0265 AC: 4036AN: 152140Hom.: 70 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4036
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0268 AC: 6703AN: 250344 AF XY: 0.0278 show subpopulations
GnomAD2 exomes
AF:
AC:
6703
AN:
250344
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0248 AC: 36218AN: 1461228Hom.: 607 Cov.: 31 AF XY: 0.0252 AC XY: 18305AN XY: 726898 show subpopulations
GnomAD4 exome
AF:
AC:
36218
AN:
1461228
Hom.:
Cov.:
31
AF XY:
AC XY:
18305
AN XY:
726898
show subpopulations
African (AFR)
AF:
AC:
1194
AN:
33450
American (AMR)
AF:
AC:
627
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
AC:
721
AN:
26108
East Asian (EAS)
AF:
AC:
3277
AN:
39620
South Asian (SAS)
AF:
AC:
3759
AN:
86176
European-Finnish (FIN)
AF:
AC:
237
AN:
53410
Middle Eastern (MID)
AF:
AC:
132
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
24667
AN:
1111638
Other (OTH)
AF:
AC:
1604
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1720
3439
5159
6878
8598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1006
2012
3018
4024
5030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0266 AC: 4051AN: 152258Hom.: 73 Cov.: 33 AF XY: 0.0258 AC XY: 1919AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
4051
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
1919
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
1499
AN:
41552
American (AMR)
AF:
AC:
268
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
95
AN:
3472
East Asian (EAS)
AF:
AC:
359
AN:
5176
South Asian (SAS)
AF:
AC:
224
AN:
4816
European-Finnish (FIN)
AF:
AC:
33
AN:
10620
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1479
AN:
68006
Other (OTH)
AF:
AC:
59
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
238
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital contractures of the limbs and face, hypotonia, and developmental delay Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -10
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.